- Home
- » Tags
- » Solidarity trial
Top View
- The Covid–19 Pandemic and Haemoglobin Disorders
- Covid-19 Policy Report August 2021
- COVID-19: Unmasking Emerging SARS-Cov-2 Variants, Vaccines and Therapeutic Strategies
- COVID-19 Health Evidence Summary No.98
- Where We Disappointed Science in COVID - the Indian Story Ashish Chauhan* All India Institute of Medical Sciences, New Delhi, India
- Repurposed Antiviral Drugs for COVID-19–Interim WHO SOLIDARITY
- 02/11/2020 Date Journal Title Study Type Country Authors Link Trial
- Master Question List for COVID-19 (Caused by SARS-Cov-2) Weekly Report 17 November 2020
- COVID-19 Update: Where We Are One Year Later Dr
- Addendum to FIP COVID-19 Guidance (November 2020)
- Who's Response to Covid-19
- Policy Brief 002 Update 06.2021
- Solidarity in the Time of COVID-19?
- A Minireview of the Promising Drugs and Vaccines in Pipeline for the Treatment of COVID-19 and Current Update on Clinical Trials
- COVID-19 Clinical Trials: Learning from Exceptions in the Research Chaos
- COVID‑19 STRATEGY UPDATE © World Health Organization 2020 Some Rights Reserved
- Prospects for SARS-Cov-2 Diagnostics, Therapeutics and Vaccines in Africa
- Policy Brief 002 Update 11.2020
- COVID-19 Vaccines and Pregnancy
- COVID-19 6.1 BCG Perspectives
- Solidarity in Response to the COVID-19 Pandemic
- Society of Actuaries Research Brief Impact of COVID-19, May 15, 2020
- COVID-19: Unmasking Emerging SARS-Cov-2 Variants, Vac- Cines and Therapeutic Strategies
- How COVID-19 Has Fundamentally Changed Clinical Research in Global Health
- 20Th WHO Regulatory Update on COVID-19
- COVID-19 Situation Report 209
- Pandemic Trials: Evidence-Based Medicine on Steroids
- Key Criteria for the Ethical Acceptability of COVID-19 Human Challenge Studies
- Master Question List for COVID-19 (Caused by SARS-Cov-2) Weekly Report 10 November 2020
- COVID Lit Review (00000008)
- Therapeutics and Covid-19: the Global Race for an Effective Treatment
- Group Crisis Management Briefing
- Identification and Development of Therapeutics for COVID-19 Authors
- Gilead Sciences Statement on the Solidarity Trial
- February 2021 About This Update
- Covid-19 Therapeutics Still Matter, Even with Vaccines
- COVID Lit Review Week 30&31 2021.Xlsx
- The Time to Offer Treatments for Covid-19
- Access to Vaccines, Therapeutics, and Diagnostics
- UHB Library & Knowledge Services Date 7 December – 13
- COVID-19 Scientific and Public Health Policy Update – 23 June 2020
- Covid-19: Trials of Four Potential Treatments to Generate “Robust Data” of What Works
- COVID-19 Update from an Infectious Diseases Perspective
- Is Veklury (Remdesivir) Approved by the FDA to Treat COVID-19? A
- Master Question List for COVID-19 (Caused by SARS-Cov-2) Weekly Report 27 October 2020
- It Takes More Than Two to Tango with COVID-19: Analyzing Argentina’S Early Pandemic Response (Jan 2020–April 2020)
- COVID-19 Vaccines: Global Health Issues
- COVID-19 Solidarity Response Fund for the World Health Organization